SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001047469-15-003819
Filing Date
2015-04-23
Accepted
2015-04-23 09:56:06
Documents
3
Period of Report
2015-06-10
Effectiveness Date
2015-04-23

Document Format Files

Seq Description Document Type Size
1 DEF 14A a2224333zdef14a.htm DEF 14A 706755
2 G16092BGI001.JPG g16092bgi001.jpg GRAPHIC 102181
3 G16092BGI002.JPG g16092bgi002.jpg GRAPHIC 80607
  Complete submission text file 0001047469-15-003819.txt   960172
Mailing Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827
Business Address 53 FRONTAGE ROAD SUITE 220 HAMPTON NJ 08827 908-200-7500
Celldex Therapeutics, Inc. (Filer) CIK: 0000744218 (see all company filings)

IRS No.: 133191702 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-15006 | Film No.: 15787113
SIC: 2835 In Vitro & In Vivo Diagnostic Substances